TP53 and cancer: In mouse models of cancer, the anti‐tumorigenic effect of telomerase inhibition is only achieved when telomeres reach a critically short length, and this effect is lost in the absence of the p53 tumor suppressor gene, which is frequently mutated in cancer (Gonzalez‐Suarez et al, 2000; Perera et al, 2008).